Shehzadi S - Search Results

1

Pharmacokinetics profile of serum and cellular Sofosbuvir along with its concentration effect analysis in HCV patients receiving Sofosbuvir and Ribavirin.

Ahmed B, Munir B, Ghaffar A, Yameen M, Jalal F, Farooq MU, Shehzadi S, Ashraf S, Liaqat A. Ahmed B, et al. Among authors: shehzadi s. Pak J Pharm Sci. 2019 May;32(3 (Supplementary)):1269-1274. Pak J Pharm Sci. 2019. PMID: 31303600 Clinical Trial.

2

Sorafenib tosylate, Ribavirn and Sofosbuvir combination therapy for HCV virus infected patients with decompensated liver cancer.

Munir B, Ahmed B, Kiran S, Jalal F, Zahoor MK, Shehzadi S, Oranab S, Kamran SK, Ghaffar A. Munir B, et al. Among authors: shehzadi s. Pak J Pharm Sci. 2017 Nov;30(6(Supplementary)):2383-2387. Pak J Pharm Sci. 2017. PMID: 29188773

3

Sanguinarine Attenuates Lung Cancer Progression via Oxidative Stress-induced Cell Apoptosis.

Ullah A, Razzaq A, Alfaifi MY, Elbehairi SEI, Menaa F, Ullah N, Shehzadi S, Nawaz T, Iqbal H. Ullah A, et al. Among authors: shehzadi s. Curr Mol Pharmacol. 2024;17:e18761429269383. doi: 10.2174/0118761429269383231119062233. Curr Mol Pharmacol. 2024. PMID: 38389415

4

A discovery of potent kaempferol derivatives as multi-target medicines against diabetes as well as bacterial infections: an in silico approach.

Parveen S, Shehzadi S, Shafiq N, Rashid M, Naz S, Mehmood T, Riaz R, S Almaary K, Nafidi HA, Bourhia M. Parveen S, et al. Among authors: shehzadi s. J Biomol Struct Dyn. 2024 Feb 9:1-23. doi: 10.1080/07391102.2024.2308773. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38334277

5

Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.

Shah FI, Shehzadi S, Akram F, Haq IU, Javed B, Sabir S, Kazim Y, Ashfaq S. Shah FI, et al. Among authors: shehzadi s. Mol Biotechnol. 2023 Dec 20. doi: 10.1007/s12033-023-00994-7. Online ahead of print. Mol Biotechnol. 2023. PMID: 38117395 Review.

6

Hypoxia A Typical Target in Human Lung Cancer Therapy.

Ullah A, Shehzadi S, Ullah N, Nawaz T, Iqbal H, Aziz T. Ullah A, et al. Among authors: shehzadi s. Curr Protein Pept Sci. 2023 Nov 29. doi: 10.2174/0113892037252820231114045234. Online ahead of print. Curr Protein Pept Sci. 2023. PMID: 38031268

7

Biological Significance of EphB4 Expression in Cancer.

Ullah A, Razzaq A, Zhou C, Ullah N, Shehzadi S, Aziz T, Alfaifi MY, Elbehairi SEI, Iqbal H. Ullah A, et al. Among authors: shehzadi s. Curr Protein Pept Sci. 2024;25(3):244-255. doi: 10.2174/0113892037269589231017055642. Curr Protein Pept Sci. 2024. PMID: 37909437 Review.

8

In-vitro Augmentation of Mesenchymal Stem Cells by Using Adult Bovine Serum.

Shehzadi S, Javed M, Ullah A, Bilal Waqar A, Iftikhar Shah F, Ullah S. Shehzadi S, et al. Curr Stem Cell Res Ther. 2023 Oct 10. doi: 10.2174/011574888X260118230927050143. Online ahead of print. Curr Stem Cell Res Ther. 2023. PMID: 37861050

9

Contemporaneous and upcoming trends in immunotherapy for prostate cancer: review.

Saleem S, Rashid AB, Shehzadi S, Mumtaz H, Saqib M, Bseiso A, Villasenor AV, Ahmed A, Sonia SN. Saleem S, et al. Among authors: shehzadi s. Ann Med Surg (Lond). 2023 Jul 7;85(8):4005-4014. doi: 10.1097/MS9.0000000000001070. eCollection 2023 Aug. Ann Med Surg (Lond). 2023. PMID: 37554896 Free PMC article.

10

Toxicological assessment of Phormidium sp. derived copper oxide nanoparticles for its biomedical and environmental applications.

Asif N, Ahmad R, Fatima S, Shehzadi S, Siddiqui T, Zaki A, Fatma T. Asif N, et al. Among authors: shehzadi s. Sci Rep. 2023 Apr 17;13(1):6246. doi: 10.1038/s41598-023-33360-3. Sci Rep. 2023. PMID: 37069201 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page